Is Maxar Technologies a Buy After Falling 30% This Week?

Does Maxar Technologies’s recent dip present investors with a buying opportunity?

| More on:

Shares of Maxar Technologies (NYSE:MAXR)(NYSE:MAXR) are down 30% this week, currently trading at $34.39 at the time of writing. The stock was decimated on the back of its less-than-impressive quarterly results. So, does the pullback provide a buying opportunity for investors?

Maxar Technologies sales rise 3%

In the March quarter, Maxar Technologies reported revenue of US$392 million — a year-over-year gain of 3%. While Maxar’s low-margin space infrastructure business saw sales grow by 17% in Q1, its high-margin earth intelligence unit experienced a decline of 8% year over year.

So, Maxar trimmed losses in the space infrastructure business, but its adjusted EBITDA in the earth intelligence segment fell by US$26 million.

This meant the company’s net loss in Q1 stood at US$1.30 per share, which was significantly higher than its prior-year loss of US$0.80 per share. Its adjusted net loss stood at US$0.23 per share compared to estimates of a net loss of US$0.22 per share.

Despite its net loss in the March quarter, Maxar’s operating cash flow was positive at US$27 million. The company did not provide any guidance for the upcoming quarters, but analysts covering the stock expect Maxar to turn profitable on a GAAP basis in Q2. Further, analysts also expect Maxar to post full-year GAAP profits in 2022, which will allow it to generate positive free cash flow on a consistent basis.

Despite its Q1 earnings miss, JPMorgan analyst Seth Seifman reiterated an “overweight” rating on Maxar with a price target of US$47. The analyst expects profitable growth in the earth intelligence segment going forward. Further, Maxar’s attractive valuation and its focus on lowering debt levels were also the reasons behind the analyst’s current views.

Growth stocks under the pump

While Maxar stock gained 140% in the last year, it is down 30% year to date. In 2021, growth stocks have underperformed the markets, as investors were concerned over its high valuation metrics. Further, rising interest rates coupled with the looming threat of inflation have contributed to the sell-off.

Analysts tracking Maxar Technologies expect the company’s sales to rise by 3.8% to US$1.8 billion in 2021 and by 8.4% to US$1.94 billion in 2022. They also expect its bottom line to improve from a loss per share of US$0.07 in 2021 to earnings per share of US$0.91 in 2022.

This suggests Maxar stock is trading at a forward price-to-2022-sales multiple of 1.31 and a price-to-earnings multiple of 39. Comparatively, Maxar is forecast to increase earnings at an annual rate of 30% in the next five years.

What’s next for investors?

Maxar Technologies is part of a highly disruptive sector and provides investors an opportunity to derive outsized gains but also carries significant risks due to its high beta score, which stands at 1.29.

Further, it has over US$2 billion in debt on its books, which is larger than its current market cap. However, the company reduced debt by US$300 million in Q1 and ended the quarter with an order book of US$1.8 billion.

Maxar’s recent decline in valuation might present contrarian investors with an attractive buying opportunity. However, the company needs to report consistent profits and lower debt levels to outperform the broader markets in 2021 and beyond.

The Motley Fool recommends MAXAR TECHNOLOGIES LTD. Fool contributor Aditya Raghunath has no position in any of the stocks mentioned.

More on Tech Stocks

Young Boy with Jet Pack Dreams of Flying
Tech Stocks

These 2 TSX Stocks Look Set to Soar in 2026 and Beyond

2 TSX stocks to buy for 2026: MDA Space (MDA) offers deep value with a massive backlog, while Descartes Systems…

Read more »

Canada Day fireworks over two Adirondack chairs on the wooden dock in Ontario, Canada
Tech Stocks

1 Dividend-Paying Tech Stock I’d Buy Before Touching Shopify

Constellation Software (TSX:CSU) might be a better value than other Canadian tech stars in 2026.

Read more »

doctor uses telehealth
Tech Stocks

Ready for Healthcare AI? Put WELL Health Technologies Plus 2 More on Your Watchlist

Three Canadian companies are sound investment options as AI adoption in the healthcare sector accelerates.

Read more »

The virtual button with the letters AI in a circle hovering above a keyboard, about to be clicked by a cursor.
Tech Stocks

Best Canadian AI Stocks to Buy Now

Three TSX-listed firms deeply involved in artificial intelligence are the best Canadian AI stocks to buy today.

Read more »

man looks worried about something on his phone
Dividend Stocks

Is BCE Stock (Finally) a Buy for its 5.5% Dividend Yield?

This beaten-down blue chip could let you lock in a higher yield as conditions normalize. Here’s why BCE may be…

Read more »

AI image of a face with chips
Tech Stocks

The Chinese AI Takeover Is Here, But This Canadian Stock Still Looks Safe

Shopify (TSX:SHOP) is not threatened by Chinese AI.

Read more »

leader pulls ahead of the pack during bike race
Tech Stocks

TSX Is Beating Wall Street This Year, and Here Are Some of the Canadian Stocks Driving the Rally

It’s not every year you see Canada outpace America on the investing front, but 2025 has shaped up differently. The…

Read more »

diversification and asset allocation are crucial investing concepts
Tech Stocks

Here Are My Top 2 Tech Stocks to Buy Now

Investors looking for two world-class tech stocks to buy today for big gains over the long term do have prime…

Read more »